MedPath

DILANTIN W PHENOBARBITAL 15MG

DILANTIN W PHENOBARBITAL 15MG

Discontinued
DIN Number

00275131

Drug Class

Human

Market Date

Dec 31, 1951

Company
HC

parke-davis division, warner-lambert canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00275131
AIG Number0201376001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
N03AB52 PHENYTOIN, COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.12
Health Canada Classification

ACTIVE INGREDIENTS (2)

PHENOBARBITALActive
Strength: 15 MG / CAP
Monograph: PHENOBARBITAL
PHENYTOIN SODIUMActive
Strength: 100 MG / CAP
Monograph: PHENYTOIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.